Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

An introduction to PET and SPECT neuroreceptor quantification models.

Ichise M, Meyer JH, Yonekura Y.

J Nucl Med. 2001 May;42(5):755-63. Review.

2.

Modeling of receptor ligand data in PET and SPECT imaging: a review of major approaches.

Meyer JH, Ichise M.

J Neuroimaging. 2001 Jan;11(1):30-9. Review.

PMID:
11198524
3.

Pharmacokinetic considerations in the PET and SPECT evaluation of CNS receptors.

Mazière B, Delforge J.

Q J Nucl Med. 1997 Jun;41(2):119-26.

PMID:
9203851
4.

Brain radioligands--state of the art and new trends.

Halldin C, Gulyás B, Langer O, Farde L.

Q J Nucl Med. 2001 Jun;45(2):139-52. Review.

PMID:
11476163
5.

Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT.

Acton PD, Choi SR, Hou C, Plössl K, Kung HF.

J Nucl Med. 2001 Oct;42(10):1556-62.

6.
7.

Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: A review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry.

Willeit M, Praschak-Rieder N.

Neuroimage. 2010 Nov 15;53(3):878-92. doi: 10.1016/j.neuroimage.2010.04.030. Epub 2010 Apr 23. Review.

PMID:
20399868
8.

Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers.

Slifstein M, Laruelle M.

Nucl Med Biol. 2001 Jul;28(5):595-608. Review.

PMID:
11516703
9.

Principles of tracer kinetic analysis.

Price JC.

Neuroimaging Clin N Am. 2003 Nov;13(4):689-704. Review.

PMID:
15024955
10.

Vulnerability of positron emission tomography radiotracers to endogenous competition. New insights.

Laruelle M, Huang Y.

Q J Nucl Med. 2001 Jun;45(2):124-38. Review.

PMID:
11476162
11.

PET/SPECT: functional imaging beyond flow.

Lammertsma AA.

Vision Res. 2001;41(10-11):1277-81. Review.

12.
13.

[Neurotransmitter-receptor-imaging].

Cordes M, Hierholzer J, Nikolai-Beyer K.

Radiologe. 1993 Nov;33(11):612-9. Review. German.

PMID:
7904078
14.

Stereoselective neuroimaging in vivo.

Smith DF, Jakobsen S.

Eur Neuropsychopharmacol. 2007 Jul;17(8):507-22. Epub 2007 Mar 23. Review.

PMID:
17368004
15.

Comparison of noninvasive quantification methods of in vivo vesicular acetylcholine transporter using [123I]-IBVM SPECT imaging.

Barret O, Mazère J, Seibyl J, Allard M.

J Cereb Blood Flow Metab. 2008 Sep;28(9):1624-34. doi: 10.1038/jcbfm.2008.53. Epub 2008 May 28.

PMID:
18506194
16.

Design of new beta1-selective adrenoceptor ligands as potential radioligands for in vivo imaging.

Kopka K, Wagner S, Riemann B, Law MP, Puke C, Luthra SK, Pike VW, Wichter T, Schmitz W, Schober O, Schäfers M.

Bioorg Med Chem. 2003 Aug 5;11(16):3513-27.

PMID:
12878144
17.

Measurement of input functions in rodents: challenges and solutions.

Laforest R, Sharp TL, Engelbach JA, Fettig NM, Herrero P, Kim J, Lewis JS, Rowland DJ, Tai YC, Welch MJ.

Nucl Med Biol. 2005 Oct;32(7):679-85.

PMID:
16243642
18.

Positron emission tomography compartmental models.

Gunn RN, Gunn SR, Cunningham VJ.

J Cereb Blood Flow Metab. 2001 Jun;21(6):635-52. Review.

PMID:
11488533
19.

Radiopharmaceutical pharmacokinetics in animals: critical considerations.

Giron MC.

Q J Nucl Med Mol Imaging. 2009 Aug;53(4):359-64. Review.

20.

Radioligands for PET and SPECT Imaging of the central noradrenergic system.

McConathy J, Kilts CD, Goodman MM.

CNS Spectr. 2001 Aug;6(8):704-9.

PMID:
15520617

Supplemental Content

Support Center